New research reveals that collagen I may accelerate harmful amylin clumping in the pancreas, worsening type 2 diabetes by ...

Bombay have identified a previously unknown trigger of diabetes in collagen -- the most abundant protein in the human body -- ...

A new study reveals how collagen plays a crucial role in worsening Type 2 diabetes. While insulin and amylin hormones work ...

According to new research at IIT Bombay one of the most common types of collagen collagen I may have a surprising and ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its investigational dual agonist targeting ...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes and overweight, non-obese ...

The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss-up to 24% with ...